Bioinformatic and Experimental Analyses Reveal That KIF4A is a Biomarker of Therapeutic Sensitivity and Predicts Prognosis in Cervical Cancer Patients.
Current medical science（2022）
Key words
kinesin superfamily 4A,cervical cancer,prognosis,chemotherapy,immunotherapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined